| 000 | 00914 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250513063935.0 | ||
| 264 | 0 | _c19940616 | |
| 008 | 199406s 0 0 eng d | ||
| 022 | _a0894-9255 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWalker, B D | |
| 245 | 0 | 0 |
_aThe rationale for immunotherapy in HIV-1 infection. _h[electronic resource] |
| 260 |
_bJournal of acquired immune deficiency syndromes _c1994 |
||
| 300 |
_aS6-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 |
_aAIDS Vaccines _xtherapeutic use |
| 650 | 0 | 4 |
_aHIV Antibodies _xbiosynthesis |
| 650 | 0 | 4 |
_aHIV Infections _ximmunology |
| 650 | 0 | 4 |
_aHIV-1 _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy, Active |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _ximmunology |
| 773 | 0 |
_tJournal of acquired immune deficiency syndromes _gvol. 7 Suppl 1 _gp. S6-13 |
|
| 999 |
_c8181828 _d8181828 |
||